View by Specialty

Trending

Stomach
September 27, 2024
5 min read
Save

Q&A: What is driving ‘disturbing’ rise in metastatic stomach cancer in young adults?

Neurology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
November 11, 2022
2 min read
Save

Preexisting neuropsychiatric conditions linked to higher risk for respiratory infections

Preexisting neuropsychiatric conditions linked to higher risk for respiratory infections

For adults in the U.K., preexisting neuropsychiatric conditions and having a prescription for a related treatment carried a significantly increased risk of severe outcomes from COVID-19 and other severe acute respiratory infections.

SPONSORED CONTENT
November 10, 2022
1 min read
Save

Neurologic effects of COVID-19 persisted among pediatric populations in 2021

Neurologic effects of COVID-19 persisted among pediatric populations in 2021

SARS-CoV-2-related neurologic effects endured among children and adolescents in the United States who were hospitalized in 2021 for COVID-19 or multisystem inflammatory syndrome, researchers reported in JAMA Neurology.

Trending

Stomach
September 27, 2024
5 min read
Save

Q&A: What is driving ‘disturbing’ rise in metastatic stomach cancer in young adults?

SPONSORED CONTENT
November 10, 2022
1 min read
Save

Cerveau Technologies partners with Lexeo Therapeutics for use of tau imaging agent

Cerveau Technologies partners with Lexeo Therapeutics for use of tau imaging agent

Cerveau Technologies Inc. has announced a license agreement with Lexeo Therapeutics Inc. that will allow Lexeo to use an investigational imaging agent from Cerveau for the assessment of neurofibrillary tangles in the brain.

SPONSORED CONTENT
November 10, 2022
12 min listen
Save

Healio Minute Podcast, Neurology Edition: Top Headlines - Week of November 7, 2022

Healio Minute Podcast, Neurology Edition: Top Headlines - Week of November 7, 2022

In this edition, we bring you more news and Healio-exclusive interviews from the American Neurological Association Annual Meeting.

SPONSORED CONTENT
November 09, 2022
1 min read
Save

Lusaris Therapeutics launches with $60M to advance novel treatments for TRD, other neuro disorders

Lusaris Therapeutics launches with $60M to advance novel treatments for TRD, other neuro disorders

Lusaris Therapeutics announced its launch with $60 million in Series A financing to advance LSR-1019, a sublingual formulation of 5-MeO-DMT for patients with treatment-resistant depression and other severe neuropsychiatric disorders.

SPONSORED CONTENT
November 09, 2022
1 min read
Save

Antihistamines could be promising adjuvant therapy for Parkinson’s disease

Antihistamines could be promising adjuvant therapy for Parkinson’s disease

CHICAGO — A literature-based discovery machine learning algorithm suggested that antihistamines could be adjuvants to levodopa for Parkinson’s disease, a poster showed at the 2022 American Neurological Association annual meeting.

SPONSORED CONTENT
November 09, 2022
2 min read
Save

BLOG: Time to get your house in order

BLOG: Time to get your house in order

So, you’ve reached consensus with your partners that it’s time to sell the practice. You’ve done your research on potential platforms/buyers, and you’ve started to engage advisers. What’s next? Time to look inward.

SPONSORED CONTENT
November 09, 2022
1 min read
Save

Recurrent head injury linked to affective dysregulation, impulse control

Recurrent head injury linked to affective dysregulation, impulse control

CHICAGO — A history of two or more head injuries was associated with mild behavioral impairment in older adults, according to a poster presentation at the 2022 American Neurological Association annual meeting.

SPONSORED CONTENT
November 08, 2022
2 min read
Save

Decision-making in patients with dementia linked to biological, external factors

Decision-making in patients with dementia linked to biological, external factors

CHICAGO — Impairments in decision-making may be among the earliest signs of cognitive decline, according to a presenter at the 2022 American Neurological Association annual meeting.

SPONSORED CONTENT
November 08, 2022
1 min read
Save

Case study: COVID-19-induced hyposmia prevented migraines triggered by strong odors

Case study: COVID-19-induced hyposmia prevented migraines triggered by strong odors

CHICAGO — COVID-19-induced hyposmia eliminated odor-induced migraine headaches in an older adult, a case study presented at the 2022 American Neurological Association’s annual meeting showed.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails